Abstract:Aim: Both of endogenous nerve growth factor and brain-derived neurotrophic factor are in the family of neurenergen, and play an important role in the development of nervous system and function of normal neuron. This study was aimed to explore the effect of notoginsenoside on the expressions of nerve growth factor and brain-derived neurotrophic factor in spinal cord following transected injury. Methos: The experiment was carried out in the Institute of Neuroscience of Kunming Medical College from June to September 2005. 1 Totally 72 healthy female SD rats of clean grade and with the body mass of (200±20) g were selected and notoginsenoside was bought from Yunnan Phytopharmaceutical Co., Ltd. 2 The rats were divided into four groups at random, sham operation group, transected spinal cord injury group, transected spinal cord injury and saline (0.5 mL/dose, peritoneal, injection)therapy group as well as transected spinal cord injury and notoginsenoside (100 mg/kg/dose) therapy group with 18 in each group. Dura mate of spinal cord was cut at T10 in rats of the sham operation group, but spinal cord was not injured. Administration was performed at minute 30, hours 4, 24, 48 and 72 after operation in the latter two groups. 3 The L1-2 spinal segments were removed out and made into frozen sections at days 3, 7 and 21 after operation (n =6), and then stained by ABC method of immunohistochemistry. Positive neurons of nerve growth factor and brain-derived neurotrophic factor in the ventral horn of spinal cord were counted. Histochemical and pathological changes of spinal cord were observed by conventional hematoxylin-eosin stain. Results: A total of 72 rats were involved in the result analysis. 1 Pathologic changes of spinal cord were apparent after transected injury such as necrosis of neural degeneration, inflammatory infiltration and so on. 2 The expression of nerve growth factor proteins was observed in normal spinal cord, mainly distributed in the cytoplasm of neurons and nucleus of glial cells. The expression of nerve growth factor was increased significantly at day 7 and still higher after spinal cord injury at day 21 than that of sham operation group (P < 0.05). Notoginsenoside promoted significantly the expression of nerve growth factor and its expression was obviously higher than that of other groups at days 3 and 7 (P < 0.05). The expression of nerve growth factor was downregulation at day 21, however, it was also exceeded to the sham operation group (P < 0.05). 3 The brain-derived neurotrophic factor proteins mainly distributed in the cytoplasm of motor neurons and there were not observed in glial cells. The expression of brain-derived neurotrophic factor was very low in normal spinal cord. The expression of brain-derived neurotrophic factor was increased significantly at day 7 after spinal cord injury (P < 0.05), but it was downregulation and no significant difference compared with that of normal spinal cord at day 21 (P > 0.05). Notoginsenoside promoted significantly the expression of brain-derived neurotrophic factor that was obviously higher than that of the control group at days 3, 7 and 21 (P < 0.05). Conclusion: Notoginsenoside can alleviate the secondary damage and promote significantly the expressions of endogenous nerve growth factor and brain-derived neurotrophic factor both in quantity and time after spinal cord injury. The findings elucidated that notoginsenoside is beneficial to the early repair of spinal cord injury.

Effects of Extract of Ginkgo Biloba Leaves(egb50)on Protein Expression of Nerve Growth Factor after Sciatic Nerve Injury in Rats

Effect of Extract of Ginkgo Biloba Leaves (egb50) on Mrna Expression of NGF after Sciatic Nerve Injury in Rats

Effect of extract of Ginkgo Biloba leaves (EGb50) on the expression of GAP-43 protein after sciatic nerve injury in rats

Effect of Extract of Ginkgo Biloba Leaves on Sciatic Nerve Regeneration in Rats

[Effect of Extract of Ginkgo Biloba Leaves on Expression of Inducible Nitric Oxide Synthase after Sciatic Nerve Injury: Experiment with Rats].

Effects of Extract of Ginkgo Biloba on Apoptosis of Neurocytes and Expression of Inducible Nitricoxide Synthuse after Spinal Cord Injury in Rats

The effect of NCGCF on the repairing of injuried sciatic nerve function

An Experimental Study on the Effect of Extract of Leave Ginkgo Biloba(egb24/6) on Protection of the Neurons and the Observation of Ultra-Structure Following Nerve Injury of Sciatic Nerve in Rats

Influence of Ginkgo Biloba Extract on Ultrastructural Changes of Sensery Neurons Following Sciatic Nerve Injury in Rats

Effect of the extract of Ginkgo Blioba leaves (EGb50) on Schwann cells to synathesize and secrete nerve growth factor

A Dose-Effect Relationship of Ginkgo Biloba Extract to Nerve Regeneration in a Rat Model.

Protective Effect of Exogenous Epidermal Growth Factor on Neuronal Damage Following Sciatic Nerve Injury in Rats

EFFECT OF EXTRACT OF GINKGO BILOBA LEAVES ON PROLIFERATION OF SCs CULTURED IN VITRO

Effects of notoginsenoside on the expressions of nerve growth factor and brain-derived neurotrophic factor in spinal cord of rats with transected injury

Protective effect of extract of ginkgo biloba on survival of motor neurons after peripheral nerve injury

Effects of "fufang Zaisheng Granule" on Expression of Growth Association Protein-43 after Sciatic Nerve Injuries in Rats

EFFECTS OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR ON THE PRODUCT OF NO AND THE ACTIVITY OF NOS IN SPINAL CORD IN RATS MODEL OF NEUROPATHIC PAIN

Experimental Study of the Extract from Radix Hedysari Et Al Local Use on the Repair of Peripheral Nerve

Effect of Glial Cell Line-Derived Neurotrophic Factor on Fos Protein Expression in the Spinal Dorsal Horn of Neuropathic Pain Rat Model

Experimental study of NGF and BDNF Gene expression in acute peripheral nerve injury

Protective Effect of EGb761 on Sensory Neurons after Peripheral Nerve Injury in Rats